Ignite Creation Date:
2024-05-05 @ 10:44 PM
Last Modification Date:
2024-10-26 @ 10:23 AM
Study NCT ID:
NCT01177397
Status:
COMPLETED
Last Update Posted:
2022-12-13
First Post:
2010-08-05
Brief Title:
Study to Assess Safety Pharmacokinetics and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors Non-Hodgkin Lymphoma or Multiple Myeloma
Sponsor:
Celgene
Organization:
Celgene
Organization Data
Organization:
Celgene
Class:
INDUSTRY
Study ID:
CC-223-ST-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None